Recent Foundation Releases
-
Collaboration will add a new multi-gene cohort of patients living with inherited retinal diseases. Data insights from the new study cohort will inform the future clinical trial design for BlueRock’s pipeline of cell therapies for treating blindness.
-
The May 9th gala will raise awareness and fund research leading to treatments and cures for blinding retinal diseases.
-
The free, online event on March 20, 2024, will feature presentations from Rachel Huckfeldt, MD, PhD, Mass Eye and Ear, and Rachelle Lin, OD, Ketchum University.
-
Foundation Fighting Blindness Launches GYROS, a Natural History Study for People with Gyrate Atrophy
Gyrate atrophy is an inherited retinal disease—causing progressive vision loss. GYROS results will help researchers design clinical trials for an emerging gyrate atrophy gene therapy.
-
Foundation Fighting Blindness Appoints Jeff Klaas as Chief Strategy and Innovation Officer
Klaas brings over twenty years of experience to lead strategies aimed at elevating engagement and revenue.
-
First of its Kind Collaboration Marries Genomics Data with World’s Largest Database of Ophthalmologic Patient Encounters to Improve Accuracy of Clinical Research.
-
Foundation Fighting Blindness Named Beneficiary for iDox Concert
Special event being held during American Academy of Ophthalmology annual conference in San Francisco, California
-
Foundation Fighting Blindness and Eone Announce Partnership
Together, the Foundation Fighting Blindness and Eone are launching a new limited-edition tactile timepiece watch, the ChangeMaker.
-
Therapeutic Targets for Dry AMD: A Foundation Fighting Blindness Webinar for Eye Care Professionals
The free, online event will feature a lecture from David Boyer, MD, a Senior Partner at Retina-Vitreous Associates Medical Group and dry AMD expert.
-
Foundation Fighting Blindness and Athletes for Hope Announce Strategic Partnership
This partnership will drive awareness for blinding diseases throughout the athletic community.